First time <scp>ACS</scp> in patients with on‐target lipid levels: Inflammation at admission and re‐event rate at follow‐up
Inflammation and Lipoprotein(a) levels were particularly prominent in patients presenting with reduced left ventricular ejection fraction. Notably, Glycoproteins A/B emerge as novel markers of inflammation in these patients. Our study highlights the significantly higher impact of inflammatory burden in patients with chest pain and high level of myocardial damage than in those with lower myocardial affectation, even when they all had lipid levels well controlled. Inflammation at the time of admission influenced the re-event rate over a follow-up period of up to 6 years.
Authors
- Alberto Cordero (ORCID: https://orcid.org/0000-0003-0000-7109)
- Lina Badimón (ORCID: https://orcid.org/0000-0002-9162-2459)
- Teresa Padró (ORCID: https://orcid.org/0000-0003-1921-954X)
- Guiomar Mendieta (ORCID: https://orcid.org/0000-0001-6652-9036)
- Natàlia Muñoz‐García (ORCID: https://orcid.org/0000-0002-2982-8982)
- Gemma Vilahur (ORCID: https://orcid.org/0000-0002-2828-8873)
- Emilio Flores (ORCID: https://orcid.org/0000-0001-7524-0808)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Hospital Universitari Sant Joan D'Alacant (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital General Universitario de Elche (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Institut de Recerca Sant Pau (ES)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1111/eci.14305
- Citations
- 5
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Sociedad Española de Cardiología
- Generalitat de Catalunya
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación